Differentiating hESC are a heterogeneous cell population. (A): Differentiation of hESC in a neuronal induction protocol. In brief, hESC (H1, H7, H9) were neurally induced on Wnt1-MS5 stromal feeder cells with the addition of 300 ng/ml Noggin [2]. Neuroectodermal precursors were then harvested at div 21 and further differentiated using patterning factors such as bFGF, FGF-8, and Shh. For details, see supplemental online methods. (B): During neuronal differentiation in vitro (div 37), continuously proliferative neural precursor cells, in this dopaminergic differentiation paradigm positive for the midbrain-marker Otx-2+, differentiated neuronal cells (TuJ1+), and remaining clusters of immature SSEA-4+stem cells are present. Scale bar: 50 μm. (C): This cellular heterogeneity of hESC differentiation can be illustrated schematically. The developmental potency of immature hESC (t1) may lead to heterogeneity with regard to developmental stage and to cell lineage. The overall population at any given time is therefore composed of different subpopulations, progeny of cells A, B, and C. Remaining immature pluripotent stem and precursor cells may proliferate and spin off progeny at later times (t1–6) and thus increase the anisochronicity of the differentiating cultures. Additionally, non-neural cells, which escape the in vitro patterning factors, develop (supplemental online material 2). Restricting the cultured cells to the population of interest would increase homogeneity and isochronicity of its derivatives for in vitro and in vivo studies. A population purified at an early developmental stage would differentiate free of contamination with unwanted cells more homogenously and synchronize toward the population of interest. Abbreviations: AA, ascorbic acid; BDNF, brain-derived neurotrophic factor; bFGF, basic fibroblast growth factor; cAMP, dibutyryl cyclic adenosine 5′ monophosphate; div, days in vitro; FGF8, fibroblast growth factor 8β; GDNF, glial cell line-derived neurotrophic factor; hESC, human embryonic stem cells; Shh, sonic hedgehog; SSEA, stage-specific embryonic antigen; β3; TuJ1, t1–6, stages of in vitro development; TGF-beta3, tumor growth factor β-III-tubulin.